Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- B of A Securities increased Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) price target from $52 to $85. B of A Securities analyst Tazeen Ahmad upgraded the stock from Neutral to Buy. Apellis Pharmaceuticals shares rose 3.7% to close at $63.87 on Monday. See how other analysts view this stock.
- Keybanc boosted the price target for Spotify Technology S.A. (NYSE: SPOT) from $210 to $255. Keybanc analyst Justin Patterson maintained an Overweight rating. Spotify shares gained 7.5% to close at $194.17 on Monday. See how other analysts view this stock.
- Canaccord Genuity increased the price target for MicroStrategy Incorporated (NASDAQ: MSTR) from $554 to $670. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. MicroStrategy shares gained 6.7% ...